Early research (Phase 1)Study completedNCT00293488What this trial is testingSL-11047 in Treating Patients With Relapsed or Refractory LymphomaWho this might be right forLymphoma Progen Pharmaceuticals 20
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Not applicableStudy completedNCT00951626What this trial is testingA Standardized Nursing Intervention Protocol for HCT PatientsWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more City of Hope Medical Center 282
Testing effectiveness (Phase 2)Study completedNCT00005985What this trial is testingFilgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's LymphomaWho this might be right forLymphoma Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Active Not RecruitingNCT04007029What this trial is testingModified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forCD19 PositiveCD20 PositiveRecurrent Chronic Lymphocytic Leukemia+11 more Jonsson Comprehensive Cancer Center 24
Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Early research (Phase 1)Study completedNCT00459212What this trial is testingGTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forAcute Undifferentiated LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)+13 more National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT05753501What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesWho this might be right forHematologic Cancer AbbVie 135
Early research (Phase 1)WithdrawnNCT00886496What this trial is testingRecombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+4 more Enzon Pharmaceuticals, Inc.
Early research (Phase 1)Ended earlyNCT00725062What this trial is testingDonor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Early research (Phase 1)Looking for participantsNCT06173518What this trial is testingCD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)Who this might be right forRelapsed or Refractory B Cell Acute Lymphoblastic LeukemiaRelapsed or Refractory B Cell Non-Hodgkin Lymphoma Autolus Limited 30
Early research (Phase 1)Study completedNCT03792256What this trial is testingPalbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)Who this might be right forLeukemia, LymphocyticLymphoblastic LymphomaT-cell Lymphoma+3 more Children's Oncology Group 12
Testing effectiveness (Phase 2)Study completedNCT01110135What this trial is testingBendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple MyelomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+26 more University of Washington 43
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Ended earlyNCT01944982What this trial is testingSalvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and LymphomaWho this might be right forRelapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma Hospital Infantil Universitario Niño Jesús, Madrid, Spain 7
Early research (Phase 1)Study completedNCT00064090What this trial is testing3-AP and Cytarabine in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Vion Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT00816413What this trial is testingDonor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of Nebraska
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Study completedNCT01139970What this trial is testingVeliparib and Temozolomide in Treating Patients With Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+13 more National Cancer Institute (NCI) 66